Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing study.
Saved in:
| Title: | Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing study. |
|---|---|
| Authors: | Mugwanya KK; Department of Global Health, University of Washington, Seattle, Washington, United States of America.; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America., Saina M; Kenya Medical Research Institute, Nairobi, Kenya., Mugo NR; Department of Global Health, University of Washington, Seattle, Washington, United States of America.; Kenya Medical Research Institute, Nairobi, Kenya., MaWhinney S; University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America., Morrow M; University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America., Schaafsma TT; Department of Global Health, University of Washington, Seattle, Washington, United States of America., Donnell D; Fred Hutchinson Center, Seattle, Washington, United States of America., Glidden DV; University of California San Francisco, San Francisco, California, United States of America., Ngure K; Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya., Brown CE; Department of Global Health, University of Washington, Seattle, Washington, United States of America., Rechkina EA; Department of Global Health, University of Washington, Seattle, Washington, United States of America., Chohan BH; Department of Global Health, University of Washington, Seattle, Washington, United States of America., Wu L; Department of Global Health, University of Washington, Seattle, Washington, United States of America.; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America., Hill E; Department of Global Health, University of Washington, Seattle, Washington, United States of America., Koome E; Kenya Medical Research Institute, Nairobi, Kenya., Akelo N; Kenya Medical Research Institute, Nairobi, Kenya., Mbaire S; Kenya Medical Research Institute, Nairobi, Kenya., Morrison SA; Department of Global Health, University of Washington, Seattle, Washington, United States of America., Kibatha M; Kenya Medical Research Institute, Nairobi, Kenya., Njeru I; Kenya Medical Research Institute, Nairobi, Kenya., Muriithi M; Kenya Medical Research Institute, Nairobi, Kenya., Coppinger C; University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America., Bushman L; University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America., Baeten JM; Department of Global Health, University of Washington, Seattle, Washington, United States of America.; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.; Department of Medicine, University of Washington, Seattle, Washington, United States of America., Anderson PL; University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America. |
| Corporate Authors: | Women Benchmark Study Team |
| Source: | PLoS medicine [PLoS Med] 2025 Sep 09; Vol. 22 (9), pp. e1004732. Date of Electronic Publication: 2025 Sep 09 (Print Publication: 2025). |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-1676 |
|---|---|
| DOI: | 10.1371/journal.pmed.1004732 |
